Arcutis Biotherapeutics Inc

NASDAQ:ARQT   3:59:54 PM EDT
21.68
+0.11 (+0.51%)
Products

Arcutis Submits Topical Roflumilast Cream New Drug Application To FDA For The Treatment Of Adults And Adolescents With Plaque Psoriasis

Published: 10/04/2021 12:42 GMT
Arcutis Biotherapeutics Inc (ARQT) - Arcutis Submits Topical Roflumilast Cream New Drug Application to FDA for the Treatment of Adults and Adolescents With Plaque Psoriasis.
Arcutis Biotherapeutics Inc - Roflumilast Cream Was Generally Well-tolerated With a Favorable Safety and Tolerability Profile.